Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection

Abstract

Multiple oral direct-acting antiviral regimens are approved for the treatment of chronic hepatitis C virus infection. This systematic review of 42 trials examines their efficacy and safety. Background: Rapid improvements in hepatitis C virus (HCV) therapy have led to the approval of multiple oral direct-acting antiviral (DAA) regimens by the U.S. Food and Drug Administration (FDA) for...